• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO化介导的细胞周期进程调控与癌症

SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

作者信息

Eifler Karolin, Vertegaal Alfred C O

机构信息

Department of Molecular Cell Biology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

出版信息

Trends Biochem Sci. 2015 Dec;40(12):779-793. doi: 10.1016/j.tibs.2015.09.006. Epub 2015 Oct 22.

DOI:10.1016/j.tibs.2015.09.006
PMID:26601932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4874464/
Abstract

Protein conjugation with Small ubiquitin-like modifier (SUMOylation) has critical roles during cell cycle progression. Many important cell cycle regulators, including many oncogenes and tumor suppressors, are functionally regulated via SUMOylation. The dynamic SUMOylation pattern observed throughout the cell cycle is ensured via distinct spatial and temporal regulation of the SUMO machinery. Additionally, SUMOylation cooperates with other post-translational modifications to mediate cell cycle progression. Deregulation of these SUMOylation and deSUMOylation enzymes causes severe defects in cell proliferation and genome stability. Different types of cancer were recently shown to be dependent on a functioning SUMOylation system, a finding that could be exploited in anticancer therapies.

摘要

蛋白质与小泛素样修饰物的缀合(SUMO化)在细胞周期进程中起关键作用。许多重要的细胞周期调节因子,包括许多癌基因和肿瘤抑制因子,通过SUMO化进行功能调节。通过SUMO机制独特的空间和时间调节,确保了在整个细胞周期中观察到的动态SUMO化模式。此外,SUMO化与其他翻译后修饰协同作用以介导细胞周期进程。这些SUMO化和去SUMO化酶的失调会导致细胞增殖和基因组稳定性出现严重缺陷。最近发现不同类型的癌症依赖于正常运作的SUMO化系统,这一发现可用于抗癌治疗。

相似文献

1
SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.SUMO化介导的细胞周期进程调控与癌症
Trends Biochem Sci. 2015 Dec;40(12):779-793. doi: 10.1016/j.tibs.2015.09.006. Epub 2015 Oct 22.
2
Sumoylation and Its Contribution to Cancer.SUMO化修饰及其在癌症中的作用
Adv Exp Med Biol. 2017;963:283-298. doi: 10.1007/978-3-319-50044-7_17.
3
Targeting SUMO Signaling to Wrestle Cancer.靶向 SUMO 信号以攻克癌症。
Trends Cancer. 2021 Jun;7(6):496-510. doi: 10.1016/j.trecan.2020.11.009. Epub 2020 Dec 20.
4
Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.靶向蛋白质 SUMOylation 的小分子抑制剂作为新型抗癌化合物。
Mol Pharmacol. 2018 Aug;94(2):885-894. doi: 10.1124/mol.118.112300. Epub 2018 May 21.
5
Cell cycle-dependent conjugation of endogenous BRCA1 protein with SUMO-2/3.内源性BRCA1蛋白与SUMO-2/3的细胞周期依赖性缀合。
Biochim Biophys Acta. 2011 Apr;1810(4):432-8. doi: 10.1016/j.bbagen.2010.12.001. Epub 2010 Dec 13.
6
Revised annotation and extended characterizations of components of the SUMOylation system.SUMO化系统组件的修订注释及扩展特征描述
Plant Direct. 2020 Sep 28;4(9):e00266. doi: 10.1002/pld3.266. eCollection 2020 Sep.
7
The post-translational modification, SUMOylation, and cancer (Review).翻译后修饰、SUMOylation 和癌症(综述)。
Int J Oncol. 2018 Apr;52(4):1081-1094. doi: 10.3892/ijo.2018.4280. Epub 2018 Feb 22.
8
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.通过使用选择性 SAH 抑制剂探索 SUMOylation 在癌细胞生物学中的作用。
Nat Chem Biol. 2017 Nov;13(11):1164-1171. doi: 10.1038/nchembio.2463. Epub 2017 Sep 11.
9
Signalling mechanisms and cellular functions of SUMO.SUMO 的信号机制和细胞功能。
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. doi: 10.1038/s41580-022-00500-y. Epub 2022 Jun 24.
10
Cell cycle-dependent SUMO-1 conjugation to nuclear mitotic apparatus protein (NuMA).细胞周期依赖性 SUMO-1 缀合到核有丝分裂器蛋白(NuMA)。
Biochem Biophys Res Commun. 2014 Jan 3;443(1):259-65. doi: 10.1016/j.bbrc.2013.11.107. Epub 2013 Dec 2.

引用本文的文献

1
Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis.通过综合生物信息学分析鉴定参与肺腺癌进展和奥希替尼耐药的SUMO化修饰因子。
Sci Rep. 2025 Aug 24;15(1):31130. doi: 10.1038/s41598-025-16615-z.
2
Role of Ionizing Radiation in Shaping the Complex Multi-Layered Epigenome.电离辐射在塑造复杂多层表观基因组中的作用。
Epigenomes. 2025 Aug 8;9(3):29. doi: 10.3390/epigenomes9030029.
3
SUMOylation-related genes define prognostic subtypes in stomach adenocarcinoma: integrating single-cell analysis and machine learning analyses.SUMO化相关基因定义胃腺癌的预后亚型:整合单细胞分析和机器学习分析
Front Immunol. 2025 Aug 1;16:1527233. doi: 10.3389/fimmu.2025.1527233. eCollection 2025.
4
Enteral nutrition intervention improves intestinal ischemia-reperfusion injury by modulating the SENP1/SIRT3 axis.肠内营养干预通过调节SENP1/SIRT3轴改善肠道缺血再灌注损伤。
J Clin Biochem Nutr. 2025 Jul;77(1):55-63. doi: 10.3164/jcbn.25-31. Epub 2025 Apr 9.
5
SUMOylation is not a prerequisite for HSF1's role in stress protection and transactivation.SUMO化不是HSF1在应激保护和反式激活中发挥作用的先决条件。
Sci Rep. 2025 Jul 5;15(1):24077. doi: 10.1038/s41598-025-08735-3.
6
Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC.靶向卵巢癌中的SUMO化修饰:敏感性、抗性及MYC的作用
iScience. 2025 Apr 29;28(6):112555. doi: 10.1016/j.isci.2025.112555. eCollection 2025 Jun 20.
7
Crosstalk between SUMOylation and ubiquitination controls the stability of transcription factor zinc finger protein 24: a novel antitumor mechanism in bladder cancer.SUMO化与泛素化之间的相互作用调控转录因子锌指蛋白24的稳定性:膀胱癌中的一种新型抗肿瘤机制
Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03450-9.
8
SUMOylation-regulated genes in colon cancer: expression patterns and clinical implications.结肠癌中SUMO化修饰调控的基因:表达模式及临床意义
Discov Oncol. 2025 May 20;16(1):837. doi: 10.1007/s12672-025-02614-z.
9
Integrative analysis of the expression profile and prognostic values of SENP gene family in hepatocellular carcinoma.肝细胞癌中SENP基因家族表达谱及预后价值的综合分析
Discov Oncol. 2025 May 13;16(1):752. doi: 10.1007/s12672-025-02598-w.
10
Nuclear pore complex protein RANBP2 and related SUMOylation in solid malignancies.核孔复合体蛋白RANBP2及相关的SUMO化修饰在实体恶性肿瘤中的作用
Genes Dis. 2024 Sep 4;12(4):101407. doi: 10.1016/j.gendis.2024.101407. eCollection 2025 Jul.

本文引用的文献

1
System-wide identification of wild-type SUMO-2 conjugation sites.全系统野生型SUMO-2缀合位点的鉴定。
Nat Commun. 2015 Jun 15;6:7289. doi: 10.1038/ncomms8289.
2
Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.小泛素样修饰激活酶亚基2(SAE2)的敲低可抑制小细胞肺癌的恶性肿瘤生长并增强化疗敏感性。
J Hematol Oncol. 2015 Jun 11;8:67. doi: 10.1186/s13045-015-0164-y.
3
The ubiquitin-like modifier FAT10 in antigen processing and antimicrobial defense.泛素样修饰因子FAT10在抗原加工及抗菌防御中的作用
Mol Immunol. 2015 Dec;68(2 Pt A):129-32. doi: 10.1016/j.molimm.2015.04.012. Epub 2015 May 14.
4
High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.高水平的SAE2促进胃癌的恶性表型并预测其预后。
Am J Cancer Res. 2015 Jan 15;5(2):589-602. eCollection 2015.
5
Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.Sentrin/小泛素样修饰物特异性蛋白酶5保护口腔癌细胞免受氧化应激诱导的细胞凋亡。
Mol Med Rep. 2015 Aug;12(2):2009-14. doi: 10.3892/mmr.2015.3662. Epub 2015 Apr 22.
6
c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.c-Myc以一种依赖于SUMO化的方式靶向蛋白酶体进行降解,这一过程受PIAS1、SENP7和RNF4调控。
Cell Cycle. 2015;14(12):1859-72. doi: 10.1080/15384101.2015.1040965.
7
Advances in the development of SUMO specific protease (SENP) inhibitors.SUMO特异性蛋白酶(SENP)抑制剂的研发进展。
Comput Struct Biotechnol J. 2015 Mar 24;13:204-11. doi: 10.1016/j.csbj.2015.03.001. eCollection 2015.
8
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.小泛素样修饰物(SUMO)途径功能丧失对癌细胞和肿瘤增殖的特征分析。
PLoS One. 2015 Apr 10;10(4):e0123882. doi: 10.1371/journal.pone.0123882. eCollection 2015.
9
SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling.SENP1抑制通过调节NF-κB信号传导诱导多发性骨髓瘤细胞凋亡和生长停滞。
Biochem Biophys Res Commun. 2015 May 1;460(2):409-15. doi: 10.1016/j.bbrc.2015.03.047. Epub 2015 Mar 17.
10
PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.PIAS3是一种STAT3抑制剂,与胃癌患者的生存率呈显著负相关。
Int J Clin Exp Med. 2015 Jan 15;8(1):682-9. eCollection 2015.